16 completed, 16 unknown, 2 recruiting, 1 not yet recruiting. 12 Not applicable, 7 Phase 2, 6 Phase 1, 3 Phase 3, 3 Phase 4.
Follow Nagoya University: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Clinical Trial of Tamibarotene for Patients With HFpEF (RELIEF Trial) Tamibarotene, Placebo - HFpEF - Heart Failure With Preserved Ejection Fraction | Phase 2 | Not yet recruiting | Nagoya University | 90 | 2026-10-01 | 2026-10-02 |
| Clinical Trial of AM80 in Combination With Gemcitabine, Cisplatin, and Nivolumab in Patients With Urothelial Carcinoma Add-on effect of adding tamivarotene (AM80) to gemcitabine, cisplatin, and nivolumab combination therapy - Urothelial Carcinoma Bladder, Urothelial Carcinoma of the Renal Pelvis and Ureter | Phase 2 | Recruiting | Nagoya University | 43 | 2025-05-01 | 2025-08-14 |
| Safety Evaluation Study for Patients With Aggressive NK-cell Leukemia PPMX-T003 - Aggressive NK Cell Leukemia | Phase 1 / Phase 2 | Recruiting | Hiroshima University Hospital | 7 | 2023-09-21 | 2025-04-30 |
| Deep Learning-based Artificial Intelligence for the Diagnosis of Small Bowel Obstruction Artificial intelligence - Bowel Obstruction, Artificial Intelligence | Unknown | Nagoya University | 17 | 2022-09-01 | 2024-07-01 | |
| Investigator-initiated Clinical Trial of MIKE-1 Am80, Gemcitabine, nab-Paclitaxel - Pancreatic Cancer | Phase 1 / Phase 2 | Unknown | Nagoya University | 55 | 2021-08-23 | 2024-04-04 |
| Hemodynamic Effects of BPA at Rest and During Exercise in CTEPH Invasive exercise testing - Chronic Thromboembolic Pulmonary Hypertension | Not applicable | Unknown | Aarhus University Hospital | 80 | 2021-01-01 | 2022-07-20 |
| The Clinical Trial of ADR-001 for IgA Nephropathy infusion of ADR-001 (Mesenchymal stem cell) - Glomerulonephritis , IGA | Phase 1 | Completed | Nagoya University | 9 | 2020-06-15 | 2023-05-01 |
| The Clinical Trial of CL2020 Cells for Neonatal Hypoxic Ischemic Encephalopathy CL2020 cells - Hypoxia-Ischemia, Brain | Phase 1 | Completed | Nagoya University | 9 | 2020-03-04 | 2023-10-03 |
| Development and Validation of a Driving Simulator for Evaluating the Residual Effects of Drugs on Driving Performance - Sensitivity Analysis Using Zopiclone As a Positive Control Road-tracking test, Car-following test, Harsh-braking test - Healthy Participants | Not applicable | Completed | Taisho Pharmaceutical Co., Ltd. | 28 | 2019-10-07 | 2025-02-28 |
| The Evaluation of Efficacy and Safety of Rituximab in Refractory CIDP Patients With IgG4 Autoantibodies Rituximab (genetical recombination), Placebo - Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) | Phase 2 | Completed | Nagoya University | 25 | 2019-03-28 | 2021-08-20 |
| CARESSES Testing and Evaluation Phases Socially-assistive Pepper robot with a CARESSES cultural competence solution, Socially-assistive control Pepper robot with an alternative CARESSES solution - Aging | Not applicable | Unknown | University of Bedfordshire | 90 | 2019-02-15 | 2019-10-14 |
| PoLyglycolic Acid Felt reiNforcEmenT of the PancreaticoJejunostomy (PLANET-PJ Trial) PGA felt reinforcement - Disease of Pancreatic or Periampullary Lesions | Phase 3 | Completed | University of Toyama | 514 | 2018-10-10 | 2026-05-05 |
| Development of Assessment Method for Driving Ability Using Driving Simulator in Healthy Volunteers #3 Road-tracking test, Car-following test, Harsh-braking test - Healthy Participants | Not applicable | Completed | Taisho Pharmaceutical Co., Ltd. | 25 | 2018-06-27 | 2025-02-28 |
| Development of Assessment Method for Driving Ability Using Driving Simulator in Healthy Volunteers #2 Road-tracking test, Car-following test, Harsh-braking test - Healthy Participants | Not applicable | Completed | Taisho Pharmaceutical Co., Ltd. | 20 | 2018-01-22 | 2025-02-28 |
| Development of Assessment Method for Driving Ability Using Driving Simulator in Healthy Volunteers #1 Road-tracking test, Car-following test, Harsh-braking test - Healthy Participants | Not applicable | Completed | Taisho Pharmaceutical Co., Ltd. | 20 | 2017-09-22 | 2025-02-28 |
| A Trial of the Irradiance Level of Phototherapy for Neonatal Jaundice High irradiance level of phototherapy, Low irradiance level of phototherapy - Neonatal Jaundice | Not applicable | Terminated | Nagoya University | 100 | 2017-07-01 | 2023-10-03 |
| Bile Usefulness for Detecting IgG4-related Sclerosing Cholangitis IgG4-related Sclerosing Cholangitis, IgG4-related Disease | Completed | Mayo Clinic | 511 | 2015-11-01 | 2022-01-05 | |
| Clinical Trial of Autologous Adipose Derived Regenerative Cells for the Treatment of Male Stress Urinary Incontinence Periurethral injection of autologous ADRCs and adipose tissue - Urinary Incontinence , Stress | Phase 3 | Completed | Nagoya University | 45 | 2015-07-29 | 2019-11-14 |
| Neoadjuvant FOLFIRINOX or Nab-paclitaxel With Gemcitabine for Borderline Resectable Pancreatic Cancer FOLFIRINOX, gemcitabine + nab-paclitaxel - Borderline Resectable Pancreatic Cancer | Phase 2 | Unknown | Nagoya University | 50 | 2015-07-01 | 2020-09-10 |
| Cytokines Associated With Cord Blood Cell Therapy for Neonatal Encephalopathy Autologous cord blood cell therapy - Neonatal Encephalopathy (Neonatal Hypoxic-ischemic Encephalopathy) | Unknown | Neonatal Encephalopathy Consortium, Japan | 18 | 2015-04-01 | 2019-10-29 |
Showing 20 of 36. Sign in to see all of them.
Hypertension (3) · Hypoxia-Ischemia, Brain (3) · Arteriosclerosis Obliterans (1) · Atrial Fibrillation (1) · Carcinoma, Transitional Cell (1) · Cardiomyopathies (1) · Cardiomyopathy, Dilated (1) · Cardiovascular Diseases (1) · Carotid Artery Diseases (1) · Cerebral Infarction (1) · Chronic Limb-Threatening Ischemia (1) · Chronic Periodontitis (1) · Coronary Disease (1) · Diabetes Mellitus (1) · Diabetes Mellitus, Type 2 (1)
tamibarotene (3) · 130-nm albumin-bound paclitaxel (2) · Gemcitabine (2) · Amlodipine (1) · Artificial Intelligence (1) · Carvedilol (1) · Cilostazol (1) · Cisplatin (1) · Continuous Positive Airway Pressure (1) · Eplerenone (1) · Population Groups (1) · Rituximab (1) · Sleep (1) · Valsartan (1) · aliskiren (1)
Japan (33) · Denmark (1) · Poland (1) · United Kingdom (1) · United States (1)
Shigeru Okuyama (3) · Toyoaki Murohara, MD, PhD (3) · Haruo Shintaku, MD, PhD (2) · Antonio Sgorbissa, ASSOC PROFESSOR (1) · Hieoo Uchida, PhD. (1) · Hiroki Kawashima (1) · Hiroshi Yamagami, MD, PhD (1) · Katsuhiro Kato, M.D. Ph.D. (1) · Kenji Yasui, MD, PhD (1) · Kenji Yasui, MD, Phd (1) · Lewis R Roberts, MB, ChB, PhD (1) · Masahiro Iijima, Ph. D (1) · Mitsuhiro Fujishiro (1) · Mitsuhiro Yokota, MD, PhD (1) · Mitsuhiro Yokota, MD,PhD (1)
PMID 21150884, PMID 17251666, PMID 19727657, PMID 20409690, PMID 21458098, PMID 22232134, PMID 24035165, PMID 28515798, PMID 28946874, PMID 30813188, PMID 31399139, PMID 32195934, PMID 32206312, PMID 35473726, PMID 35692547, PMID 38849479, PMID 39186380, PMID 39401019, PMID 39585936, PMID 40588385, PMID 40728222, PMID 41592914